Samumed is a leader in medical research and development for tissue-level regeneration. With their platform's origins in small molecule-based Wnt pathway modulation, they develop therapeutics to address a range of degenerative diseases, regenerative medicine and oncology.

Biotechnology

Samumed

Osman Kibar

Labed al Dabbagh

Robert O.

Sam Namiq

Chidozie Ugwumba

Amy Halseth

Mark Fineman

Arman Oruc

Yusuf Yazici

Jonathan Wygant

Hadi Falahatpisheh

Morton Sanger

Darrin M. Beaupre

Gary Choy

Thomas Bicsak

Christopher Swearingen

Edward Lee

Scott W. Bulcao

Erich Horsley

Michael A. White

Cevdet Samikoglu

Leadership Team

Clinical Development and Medical Affairs

Marketing and Commercial Team

Regulatory and Administrative Affairs

Teams at Samumed

Leadership Team

Clinical Development and Medical Affairs

Marketing and Commercial Team

Regulatory and Administrative Affairs